BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

530 related articles for article (PubMed ID: 22577011)

  • 1. Mass spectrometry-based targeted quantitative proteomics: achieving sensitive and reproducible detection of proteins.
    Boja ES; Rodriguez H
    Proteomics; 2012 Apr; 12(8):1093-110. PubMed ID: 22577011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ICPL--isotope-coded protein label.
    Kellermann J
    Methods Mol Biol; 2008; 424():113-23. PubMed ID: 18369857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of mass spectrometry in proteomics.
    Guerrera IC; Kleiner O
    Biosci Rep; 2005; 25(1-2):71-93. PubMed ID: 16222421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted proteomics by selected reaction monitoring mass spectrometry: applications to systems biology and biomarker discovery.
    Elschenbroich S; Kislinger T
    Mol Biosyst; 2011 Feb; 7(2):292-303. PubMed ID: 20976349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mass spectrometric discovery and selective reaction monitoring (SRM) of putative protein biomarker candidates in first trimester Trisomy 21 maternal serum.
    Lopez MF; Kuppusamy R; Sarracino DA; Prakash A; Athanas M; Krastins B; Rezai T; Sutton JN; Peterman S; Nicolaides K
    J Proteome Res; 2011 Jan; 10(1):133-42. PubMed ID: 20499897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protocol for Standardizing High-to-Moderate Abundance Protein Biomarker Assessments Through an MRM-with-Standard-Peptides Quantitative Approach.
    Percy AJ; Yang J; Chambers AG; Mohammed Y; Miliotis T; Borchers CH
    Adv Exp Med Biol; 2016; 919():515-530. PubMed ID: 27975233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitation of target proteins and post-translational modifications in affinity-based proteomics approaches.
    Kiernan UA
    Expert Rev Proteomics; 2007 Jun; 4(3):421-8. PubMed ID: 17552926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolution of seed allergen quantification--from antibodies to mass spectrometry.
    Stevenson SE; Houston NL; Thelen JJ
    Regul Toxicol Pharmacol; 2010 Dec; 58(3 Suppl):S36-41. PubMed ID: 20627116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Industrialized MS-based proteomics in the search for circulating biomarkers.
    Migneault I; Hunter JM
    Bioanalysis; 2009 Sep; 1(6):1149-63. PubMed ID: 21083081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coupling immunoaffinity techniques with MS for quantitative analysis of low-abundance protein biomarkers.
    Ackermann BL; Berna MJ
    Expert Rev Proteomics; 2007 Apr; 4(2):175-86. PubMed ID: 17425454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in computational analysis of mass spectrometry for proteomic profiling.
    Sun CS; Markey MK
    J Mass Spectrom; 2011 May; 46(5):443-56. PubMed ID: 21500303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification, Quantification, and Site Localization of Protein Posttranslational Modifications via Mass Spectrometry-Based Proteomics.
    Ke M; Shen H; Wang L; Luo S; Lin L; Yang J; Tian R
    Adv Exp Med Biol; 2016; 919():345-382. PubMed ID: 27975226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gel-free mass spectrometry-based high throughput proteomics: tools for studying biological response of proteins and proteomes.
    Roe MR; Griffin TJ
    Proteomics; 2006 Sep; 6(17):4678-87. PubMed ID: 16888762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Highly multiplexed targeted proteomics using precise control of peptide retention time.
    Gallien S; Peterman S; Kiyonami R; Souady J; Duriez E; Schoen A; Domon B
    Proteomics; 2012 Apr; 12(8):1122-33. PubMed ID: 22577013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-content affinity-based proteomics: unlocking protein biomarker discovery.
    Brody EN; Gold L; Lawn RM; Walker JJ; Zichi D
    Expert Rev Mol Diagn; 2010 Nov; 10(8):1013-22. PubMed ID: 21080818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomics: from hypothesis to quantitative assay on a single platform. Guidelines for developing MRM assays using ion trap mass spectrometers.
    Han B; Higgs RE
    Brief Funct Genomic Proteomic; 2008 Sep; 7(5):340-54. PubMed ID: 18579614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ICPL labeling strategies for proteome research.
    Lottspeich F; Kellermann J
    Methods Mol Biol; 2011; 753():55-64. PubMed ID: 21604115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global and targeted quantitative proteomics for biomarker discovery.
    Veenstra TD
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 847(1):3-11. PubMed ID: 17023222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Data management in mass spectrometry-based proteomics.
    Martens L
    Methods Mol Biol; 2011; 728():321-32. PubMed ID: 21468958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mass spectrometry-based clinical proteomics: head-and-neck cancer biomarkers and drug-targets discovery.
    Matta A; Ralhan R; DeSouza LV; Siu KW
    Mass Spectrom Rev; 2010; 29(6):945-61. PubMed ID: 20945361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.